Biggest News Aggregation in the World
📰 Peter Luo News

Page 6 - Peter Luo News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Peter Luo. Real-time updates on events, politics, business and more.

Adagene : Announces FDA Clearance to Proceed with Phase 1b/2 Trial of Anti-CTLA-4 ADG126 SAFEbody® in Combination Therapy With Anti-PD-1 Antibody Pembrolizumab - Form 6-K

Adagene Announces FDA Clearance to Proceed with Phase 1b/2 Trial of Anti-CTLA-4 ADG126 SAFEbody® in Combination Therapy With Anti-PD-1 Antibody Pembrolizumab - ADG126-P001... | March 16, 2022
United States Asia Pacific Peter Luo Adagene Inc Exchange Commission European Union

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Adagene Announces First Patient Dosed with Novel, Proprietary Combination of Anti-CD137 Agonist, ADG106, and Anti-CTLA-4 Monoclonal Antibody, ADG116

SAN DIEGO and SUZHOU, China, Jan. 27, 2022 -- Adagene Inc. , a company transforming the discovery and development of novel antibody-based therapies, today announced the first patient has been... | January 27, 2022
United States Asia Pacific Bruce Mackle Peter Luo Anthonyw Tolcher Adagene Inc

Adagene Expands Scientific and Strategic Advisory Board with Appointment of David Gandara, M.D.

Adagene Expands Scientific and Strategic Advisory Board with Appointment of David Gandara, M.D. GlobeNewswire January 19, 2022 - Dr. Gandara, Professor and Senior Advisor to the Thoracic Oncology Program at University of California Davis, brings deep expertise and strategic vision in cancer drug and biomarker development- SAN DIEGO and SUZHOU, China, Jan....
United States David Gandara Bruce Mackle Peter Luo Adagene Inc Lung Committee For The

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science